Effects of carvedilol on oxygen uptake and heart rate kinetics in patients with chronic heart failure at simulated altitude

European Journal of Preventive Cardiology

Volumn 19, Issue 3, 2012, Pages 444-451

  Karsten, Marlus ^a,b   Contini, Mauro ^a   Cefalù, Claudia ^a   Cattadori, Gaia ^a   Palermo, Pietro ^a   Apostolo, Anna ^a   Bussotti, Maurizio ^c   Magrì, Damiano ^d   Salvioni, Elisabetta ^a   Farina, Stefania ^a   Sciomer, Susanna ^e   Catai, Aparecida Maria ^b   Agostoni, Piergiuseppe ^a,f,g  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c IRCCS   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

betablockers; efficiency; Exercise test; hypoxia; oxygen consumption

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR; AMIODARONE; BETA ADRENERGIC RECEPTOR; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ALTITUDE; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; DRUG EFFECT; EXERCISE; FEMALE; HEART FAILURE; HEART RATE; HUMAN; HYPOXIA; KINETICS; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; WORKLOAD;

ADRENERGIC ANTAGONISTS; AGED; ALTITUDE; ANOXIA; CARBAZOLES; CHRONIC DISEASE; EXERCISE TEST; FEMALE; HEART FAILURE; HEART RATE; HUMANS; KINETICS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION; PROPANOLAMINES; TREATMENT OUTCOME;

EID: 84865540425     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711402736     Document Type: Article

References (35)

1. Agostoni P, Cattadori G, Guazzi M, Bussotti M, Conca C, Lomanto M, et al. Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure. Am J Med. 2000 ; 109: 450-455
2. Agostoni PG, Bussotti M, Palermo P, Guazzi M. Does lung diffusion impairment affect exercise capacity in patients with heart failure?. Heart. 2002 ; 88: 453-459 (Pubitemid 35221951)
3. Piepoli MF, Corra U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006 ; 13: 150-164 (Pubitemid 44097718)
4. Piepoli MF, Corra U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part II: How to perform cardiopulmonary exercise testing in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006 ; 13: 300-311 (Pubitemid 44318638)
5. Cleuziou C, Perrey S, Lecoq AM, Candau R, Courteix D, Obert P. Oxygen uptake kinetics during moderate and heavy intensity exercise in humans: the influence of hypoxia and training status. Int J Sports Med. 2005 ; 26: 356-362 (Pubitemid 40834703)
6. Agostoni P, Bianchi M, Moraschi A, Palermo P, Cattadori G, La Gioia R, et al. Work-rate affects cardiopulmonary exercise test results in heart failure. Eur J Heart Fail. 2005 ; 7: 498-504 (Pubitemid 40732978)
7. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986 ; 60: 2020-2027 (Pubitemid 16066969)
8. Hansen JE, Sue DY, Oren A, Wasserman K. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol. 1987 ; 59: 669-674 (Pubitemid 17047341)
9. Belardinelli R, Zhang YY, Wasserman K, Purcaro A, Agostoni PG. A four-minute submaximal constant work rate exercise test to assess cardiovascular functional class in chronic heart failure. Am J Cardiol. 1998 ; 81: 1210-1214 (Pubitemid 28226133)
10. Agostoni P, Contini M, Magini A, Apostolo A, Cattadori G, Bussotti M, et al. Carvedilol reduces exercise-induced hyperventilation: a benefit in normoxia and a problem with hypoxia. Eur J Heart Fail. 2006 ; 8: 729-735 (Pubitemid 44637272)
11. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. 2004 ; 25: 1341-1362
12. Agostoni P, Guazzi M, Bussotti M, De Vita S, Palermo P. Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients. Chest. 2002 ; 122: 2062-2067 (Pubitemid 36054183)
13. Agostoni P, Apostolo A, Cattadori G, Salvioni E, Berna G, Antonioli L, et al. Effects of beta-blockers on ventilation efficiency in heart failure. Am Heart J. 2010 ; 159: 1067-1073
14. Magri D, Palermo P, Cauti FM, Contini M, Farina S, Cattadori G, et al. Chronotropic Incompetence and functional capacity in chronic heart failure: no role of beta-blockers and beta-blocker dose. Cardiovasc Ther. 2010 ;:
15. De Cort SC, Innes JA, Barstow TJ, Guz A. Cardiac output, oxygen consumption and arteriovenous oxygen difference following a sudden rise in exercise level in humans. J Physiol. 1991 ; 441: 501-512
16. Kemps HM, Schep G, Hoogsteen J, Thijssen EJ, De Vries WR, Zonderland M, et al. Oxygen uptake kinetics in chronic heart failure: clinical and physiological aspects. Neth Heart J. 2009 ; 17: 238-244
17. Marshall JM. Peripheral chemoreceptors and cardiovascular regulation. Physiol Rev. 1994 ; 74: 543-594 (Pubitemid 24224339)
18. Walsh MP, Marshall JM. The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide. J Physiol. 2006 ; 575: 263-275 (Pubitemid 44178143)
19. Ray CJ, Marshall JM. Measurement of nitric oxide release evoked by systemic hypoxia and adenosine from rat skeletal muscle in vivo. J Physiol. 2005 ; 568: 967-978 (Pubitemid 41646035)
20. Pyner S, Coney A, Marshall JM. The role of free radicals in the muscle vasodilatation of systemic hypoxia in the rat. Exp Physiol. 2003 ; 88: 733-740 (Pubitemid 37483903)
21. Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, et al. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol. 1987 ; 63: 531-539 (Pubitemid 17161953)
22. Karliner JS, Sarnquist FF, Graber DJ, Peters RM, West JB. The electrocardiogram at extreme altitude: experience on Mt. Everest. Am Heart J. 1985 ; 109: 505-513 (Pubitemid 16256701)
23. Wolfel EE, Groves BM, Brooks GA, Butterfield GE, Mazzeo RS, Moore LG, et al. Oxygen transport during steady-state submaximal exercise in chronic hypoxia. J Appl Physiol. 1991 ; 70: 112-136
24. Wolfel EE, Selland MA, Cymerman A, Brooks GA, Butterfield GE, Mazzeo RS, et al. O2 extraction maintains O2 uptake during submaximal exercise with beta-adrenergic blockade at 4,300 m. J Appl Physiol. 1998 ; 85: 1092-1102 (Pubitemid 28413292)
25. Bender PR, Groves BM, McCullough RE, McCullough RG, Huang SY, Hamilton AJ, et al. Oxygen transport to exercising leg in chronic hypoxia. J Appl Physiol. 1988 ; 65: 2592-2597 (Pubitemid 19026427)
26. Mazzeo RS, Bender PR, Brooks GA, Butterfield GE, Groves BM, Sutton JR, et al. Arterial catecholamine responses during exercise with acute and chronic high-altitude exposure. Am J Physiol. 1991 ; 261: E419 - E424
27. Agostoni P, Wasserman K, Perego GB, Marenzi GC, Guazzi M, Assanelli E, et al. Oxygen transport to muscle during exercise in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 1997 ; 79: 1120-1124 (Pubitemid 27217074)
28. Richardson DW, Kontos HA, Raper AJ, Patterson JL. Modification by beta-adrenergic blockade of the circulatory responses to acute hypoxia in man. J Clin Invest. 1967 ; 46: 77-85
29. Pedersen ME, Cockcroft JR. The vasodilatory beta-blockers. Curr Hypertens Rep. 2007 ; 9: 269-277 (Pubitemid 47377026)
30. Coney AM, Marshall JM. Contribution of alpha2-adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat. J Physiol. 2007 ; 582: 1349-1359 (Pubitemid 47104358)
31. Marshall JM, Metcalfe JD. Analysis of the cardiovascular changes induced in the rat by graded levels of systemic hypoxia. J Physiol. 1988 ; 407: 385-403 (Pubitemid 19006180)
32. Mian R, Marshall JM. The roles of catecholamines in responses evoked in arterioles and venules of rat skeletal muscle by systemic hypoxia. J Physiol. 1991 ; 436: 499-510
33. Weisbrod CJ, Minson CT, Joyner MJ, Halliwill JR. Effects of regional phentolamine on hypoxic vasodilatation in healthy humans. J Physiol. 2001 ; 537: 613-621 (Pubitemid 33130515)
34. Dinenno FA. Hypoxic regulation of blood flow in humans. Alpha-adrenergic receptors and functional sympatholysis in skeletal muscle. Adv Exp Med Biol. 2003 ; 543: 237-248 (Pubitemid 38183728)
35. Agostoni P, Valentini M, Magri D, Revera M, Caldara G, Gregorini F, et al. Disappearance of isocapnic buffering period during increasing work rate exercise at high altitude. Eur J Cardiovasc Prev Rehabil. 2008 ; 15: 354-358